Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
| Үндсэн зохиолчид: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Frontiers Media
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
-н: Helen L. Stark, зэрэг
Хэвлэсэн: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
-н: Alzhrani, AI
Хэвлэсэн: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
-н: Honeyman, C, зэрэг
Хэвлэсэн: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
-н: Honeyman, C, зэрэг
Хэвлэсэн: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
-н: Maja-Theresa Dieterlen, зэрэг
Хэвлэсэн: (2021-08-01)